Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”
Daewoong Pharmaceutical confirms the treatment effect of COVID-19 in Hoystar tablet ‘2a clinical trial’
Daewoong Pharmaceutical confirms the effect of Hoystar tablet COVID-19 treatment in Phase 2a clinical trial
